Attached files

file filename
EX-99.1 - EX-99.1 - REVA Medical, Inc.d322020dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 23, 2012

 

 

 

REVA MEDICAL, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-54192   33-0810505

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

5751 Copley Drive, San Diego, CA 92111

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (858) 966-3000

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 7.01 Regulation FD Disclosure.

On March 23, 2012 (Australian Eastern Daylight Time), REVA Medical, Inc. (the “Company”) filed a shareholder update newsletter with the ASX that is being distributed to all shareholders of record as of March 21, 2012. A copy of the ASX filing is attached to this report as Exhibit 99.1.

Limitation of Incorporation by Reference

In accordance with General Instruction B.2. of Form 8-K, this information, including Exhibit 99.1, is furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Item 7.01 of this Current Report on Form 8-K will not be deemed an admission as to the materiality of any information that is required to be disclosed solely by Regulation FD.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit No.

  

Description

99.1    Shareholder newsletter filed with ASX on March 23, 2012.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   REVA Medical, Inc.
Date: March 23, 2012   

/s/ Katrina Thompson

   Katrina Thompson
   Chief Financial Officer
   (principal financial and accounting officer)


Index to Exhibits

 

Exhibit

Number

  

Description of Exhibits

99.1    Shareholder newsletter filed with ASX on March 23, 2012.